877441

ORANGE COUNTY SHERIFF'S OFFICE TRAINING BULLETIN Effective Date: February 22, 2023  Amends - TB 16 -1 (January 8, 2019 ) Number: 16-1 Distribution: All Personnel Review Month: August Reviewing Authority: HRD / Training Subject: Naloxone H CI Nasal Spray This training bulletin consists of the following: 1. Purpose 2. Definitions 3. Procedures 1. Purpose The purpose of this training bulletin is to provide agency personnel with guidelines governing the administration of Naloxone hydrochloride by trained personnel of the Orange County Sheriff’s Office (OCSO). The objective is for trained agency personnel to treat susp ected opioid overdoses as outlined in FS 381.887 to reduce injuries and fatalities when agency personnel arrive at the scene before emergency medical personnel. 2. Definitions A. 911 Good Samaritan Act - A person acting in good faith who seeks medical assistance for a person experiencing a drug -related overdose may not be charged, prosecuted, or penalized for possessi on of a controlled substance if the evidence relating to such possession was obtained as a result of the person seeking medical assistance. It also provides that a person, who experiences a drug -related overdose and needs medical assistance, may not be cha rged, prosecuted, or penalized for possession of a controlled substance if the evidence relating to such possession was obtained as a result of the overdose and need for medical assistance. (FS 893.21 ) B. Antagonist – a drug that counteracts the effects of another drug. C. Emergency Treatment for Suspected Opioid Overdose - Emergency responders, including law enforcement officers, are authorized to possess, store, and administer emergency opioid antagonists as clinically indicated. Civil immunity is provided for those who possess, administer, prescribe, dispense, and store in compliance with the Good Samaritan Act. ( FS 381.887 ) D. FDA – Food and Drug Administration E. Good Samaritan Act - Any person who gratuitously and in good faith renders emergency care or treatment either in direct response to emergency situations related to and arising out of a public health emergency or at the scene of an emergency outside of a hospital, doctor's offi ce, or other place having proper 16-1, Page 2 of 7 medical equipment, without objection of the injured patient or patients thereof, shall not be held liable for any civil damages as a result of such care or treatment or as a result of any act or failure to act in providing or arranging further medical treatment where the person acts as an ordinary reasonably prudent person would have acted under the same or similar circumstances. (FS 768.13 ) F. Leave Behind Naloxone Kit – a kit composed of one dose of Naloxone HCI spray, an instruction sheet and resource card. This kit is available for personnel to hand out to individuals or family members who pose a risk of future overdoses. G. Naloxone HCI nasa l spray – 4 mg of Naloxone hydrochloride which is a medicine used for the emergency treatment of known or suspected opioid overdose in adults and children. It is an opioid antagonist as it quickly reverses the effects of opioids but it is only temporary. Therefore, it is not a substitute for emergency medical care. Each Naloxone HCI nasal spray contains only one dose of the medicine and cannot be reused . The medicine in the Naloxone HCI nasal spray does not affect people who are not taking opioid medicine s. It has been approved by the FDA . H. Office of the Medical Director’s Standing Order – a formal document signed by the Orange County Office of the Medical Director authorizing trained agency personnel to administer Naloxone HCI nasal spray to persons at risk of experiencing a suspected opioid -related overdose. The Standing Order is to be renewed annually by Orange County’s Office of the Medical Director. I. Opioid Overdose – the ingestion of an excessive dose of heroin or opiate based prescription drugs su ch as methadone, fentanyl, oxycodone, hydrocodone, morphine, and codeine and name -brand drugs such as Percocet, Vicodin, and Demerol. Indicators of an opioid overdose are the patient will not wake up, will not respond to your voice or touch, breathing is very slow, irregular, or has stopped, “pinpoint pupils,” or bluish lips. J. Recovery Position – a first aid position to protect the airway of an unconscious or semi -unconscious person. The patient is laid on one side with the underneath leg straight while the other leg is fully flexed at the hip, with the knee bent and resting on the ground, to prevent rolling onto the back. The head is supported by the arm, maintaining the desired position with the face tilted towards the ground. 3. Procedures A. Training 1. Initial Training Agency personnel issued Naloxone HCI nasal spray shall receive initial training which will include an overview of the Florida law permitting the law enforcement deployment of Naloxone HCI nasal spray, patient assessment (e.g., signs and sym ptoms of an overdose), universal precautions, summoning medical attention, and the administration of the Naloxone HCI nasal spray. This training was developed in